Hemo China Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 156

Employees

  • Latest Deal Type
  • IPO
  • (Cancelled)

  • Investors
  • 9

Hemo China General Information

Description

Manufacturer, provider and developer of innovative interventional medical devices designed for cerebrovascular diseases. The company focuses on research in the field of minimally invasive interventional treatment of vascular diseases, and provides overall neuro-intervention solutions for ischemic stroke, hemorrhagic stroke and intracranial vascular stenosis, enabling patients with interventional medical devices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Floor 6M, Building 5, District 4, Hanwei International Plaza
  • Fengtai District
  • Beijing
  • China
+86 0631
Primary Industry
Surgical Devices
Corporate Office
  • Floor 6M, Building 5, District 4, Hanwei International Plaza
  • Fengtai District
  • Beijing
  • China
+86 0631

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hemo China Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 25-Aug-2022 Cancelled Generating Revenue
4. Later Stage VC (Series C) 05-Jan-2021 Completed Generating Revenue
3. Early Stage VC (Series B) 10-Oct-2020 Completed Generating Revenue
2. Early Stage VC (Series A1) 25-Apr-2020 $11.5M $21.5M Completed Generating Revenue
1. Early Stage VC (Series A) 22-Sep-2017 $27M $10M Completed Generating Revenue
To view Hemo China’s complete valuation and funding history, request access »

Hemo China Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer, provider and developer of innovative interventional medical devices designed for cerebrovascular diseases.
Surgical Devices
Beijing, China
156 As of 2021

Vapi, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hemo China Competitors (1)

One of Hemo China’s competitors is Meril Life Sciences, a Private Equity-Backed company based in Vapi, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meril Life Sciences Private Equity-Backed Vapi, India
You’re viewing 1 of 1 competitors. Get the full list »

Hemo China Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hemo China Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hudson Bay Capital Management Asset Manager Minority
LAV (Lilly Asia Fund) Corporate Venture Capital Minority
Octagon Capital Advisors Hedge Fund Minority
OrbiMed Growth/Expansion Minority
Trustbridge Partners Growth/Expansion Minority
You’re viewing 5 of 9 investors. Get the full list »

Hemo China FAQs

  • When was Hemo China founded?

    Hemo China was founded in 2016.

  • Where is Hemo China headquartered?

    Hemo China is headquartered in Beijing, China.

  • What is the size of Hemo China?

    Hemo China has 156 total employees.

  • What industry is Hemo China in?

    Hemo China’s primary industry is Surgical Devices.

  • Is Hemo China a private or public company?

    Hemo China is a Private company.

  • What is Hemo China’s current revenue?

    The current revenue for Hemo China is .

  • How much funding has Hemo China raised over time?

    Hemo China has raised $121M.

  • Who are Hemo China’s investors?

    Hudson Bay Capital Management, LAV (Lilly Asia Fund), Octagon Capital Advisors, OrbiMed, and Trustbridge Partners are 5 of 9 investors who have invested in Hemo China.

  • Who are Hemo China’s competitors?

    Meril Life Sciences is a competitor of Hemo China.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process